CLARANOVA – Q1 2018-2019 revenue: growth acceleration confirmed: +61% to €48,2 million.
Paris, France – November 7, 2018. The Claranova group announced today consolidated Q1 revenue (July 1 to September 30,
See moreSPINEWAY – Subscription of first tranche of 100 OCEANE with attached warrants for a par value of 1 M of euros.
Spineway (the “Company”) announces the exercise, on 1st november 2018, by the European High Growth Opportunities Securitization Fund of
See moreSPINEWAY – 2018 half-year results. Revenue for first nine months at €4.8M. Moving forward in the US.
Results reflect the drop in activity. Spineway confirms its strategic repositioning with revenue for the first half of the
See moreSPINEWAY – Marketing of new Mont-Blanc Evo product line authorized in the United States.
This development of the flagship Mont-Blanc line that is already distributed on territory provides surgeons with an implant that
See more
CLARANOVA – Will be present at the Berenberg Pan-European Discovery Conference USA 2018.
Paris, France – October 16, 2018. The Claranova group announces its presence at the American edition of the Berenberg
See more
CLARANOVA – Return to operating profitability confirmed in FY 2017-2018
Paris, France – October 2, 2018. Claranova reports significant across-the-board improvements in results for FY 2017- 2018, confirming its
See moreSPINEWAY – Presents its new Mont-Blanc Evo line at the Eurospine 2018 conference.
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), gave a preview of
See more
CLARANOVA – PlanetArt launches its FreePrints apllication in India.
Paris, France – September 26, 2018. PlanetArt, a subsidiary of the Claranova group, has taken its first steps in
See moreSPINEWAY – Early redemption of 44 “ORNANE” Notes. End of bond financing (ORNANE).
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), announces the early redemption
See more
